Phase II study of gefitinib in patients with advanced salivary gland cancers. - Jakob JA; Kies MS; Glisson BS; Kupferman ME; Liu DD; Lee JJ; El-Naggar AK; Gonzalez-Angulo AM; Blumenschein GR Jr (Head & neck, 2015)